Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Pancreatic Neuroendocrine Tumors × Sunitinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Carcinoma, Renal Cell 13 Gastrointestinal Stromal Tumors 3 Neoplasms 2 Kidney Neoplasms 2 Urogenital Neoplasms 1 Pancreatic Neuroendocrine Tumors 1 Kidney Diseases 1 Hypertension 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma 1 Adenoma, Islet Cell 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02282059 2024-06-20

The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors

Pfizer

100 enrolled 13 charts

EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡